Epithalon (Epitalon) · Research brief

Epitalon vs Pinealon: Are They the Same Peptide?

Real Peptides Research TeamEditorial

Updated September 30, 20269 min read

41 WORDS

Short answer

No. They are two distinct synthetic peptides that share a research lineage, a naming convention and a shelf position in most catalogs. Pinealon is a tripeptide. Epitalon is a tetrapeptide. Not one amino acid in their sequences occupies the same position.

Key takeaways

Pinealon is the tripeptide Glu-Asp-Arg and Epitalon is the tetrapeptide Ala-Glu-Asp-Gly, so the answer to whether pinealon and epitalon are the same is a straightforward no.
Despite its name, Pinealon's published research is predominantly neuronal rather than pineal, while Epitalon is the peptide actually derived from a pineal tissue preparation.
The molecular weights differ by roughly 28 Da, which means identity between the two can be confirmed from a certificate of analysis rather than argued about.
In epitalon vs pinealon comparisons for sleep, Epitalon maps onto circadian rhythm research and Pinealon maps onto neuronal stress models, which are different endpoints entirely.
DSIP is a nine-residue peptide whose original isolation was tied directly to delta-wave sleep, making it the most literature-aligned option for sleep-architecture study designs.
All three compounds are research-use-only materials, are not approved drugs, and are not supplied for human or veterinary consumption.

Our team fields the epitalon vs pinealon question more often than almost any other short-peptide query, and the confusion makes sense. Both trace back to the same school of Russian peptide bioregulator research, both get labelled pineal compounds in supplier copy, and both surface in the same circadian and cognition discussions. The sequences, the molecular weights and the published literature tell a far cleaner story.

Is Pinealon and Epitalon the same peptide?

No. Pinealon is the tripeptide Glu-Asp-Arg (EDR), molecular weight roughly 418 Da. Epitalon is the tetrapeptide Ala-Glu-Asp-Gly (AEDG), roughly 390 Da. In the epitalon vs pinealon comparison, Epitalon research concentrates on pineal and telomerase endpoints, while Pinealon research concentrates on neuronal resilience under stress. Two molecules, two separate bodies of literature.

The over-simplification worth correcting is the assumption baked into the names. Pinealon sounds like the pineal peptide and Epitalon sounds like something unrelated, when the reverse is closer to accurate: Epitalon is the synthetic analog of Epithalamin, a peptide preparation originally derived from pineal tissue, while most published Pinealon work sits in cortical and neuronal models. This article covers the structural differences, what each peptide's literature actually measures, how both compare with DSIP in sleep research, and what co-exposure studies report.

Same research lineage, two different molecules

Both compounds come out of the short peptide bioregulator tradition associated with Vladimir Khavinson and the St. Petersburg Institute of Bioregulation and Gerontology. That work is built around very short amino acid chains, typically two to four residues, proposed to act through gene expression regulation rather than classical receptor agonism. Shared origin is why pinealon and epitalon get grouped together. It is not a reason to treat them as interchangeable.

Epitalon (also written Epithalon or Epithalone): Ala-Glu-Asp-Gly. Four residues, roughly 390 Da, synthetic analog of the pineal-derived preparation Epithalamin.
Pinealon: Glu-Asp-Arg. Three residues, roughly 418 Da. The C-terminal arginine gives the molecule a basic character Epitalon lacks, which changes its solubility behaviour and its proposed interaction with nucleic acids.

So, is pinealon and epitalon the same? Not chemically, not in the research record, and not in how a laboratory would characterise them. Two different masses, two different HPLC retention profiles, two different identity confirmations. Anyone working through epitalon vs pinealon should start at that level and pull the certificates of analysis before comparing anything else. In our experience reviewing supplier listings across this category, outright mislabeling is rare, but marketing copy that blurs the two compounds into one concept is extremely common.

What the published research actually measures for each peptide

Epitalon research clusters around the pineal gland and cellular aging. The literature reports effects on the rhythm and amplitude of melatonin secretion in aged animal models, changes in antioxidant enzyme expression, and telomerase activity in cultured human somatic cells, with telomere elongation described in fibroblast culture work. The through-line is circadian and replicative: what happens to a rhythm, and what happens to a cell's replicative ceiling.

Pinealon research sits somewhere else entirely. The EDR tripeptide appears most often in neuroprotection models, including cortical neuron cultures under hypoxic or oxidative stress, apoptosis markers, and behavioural endpoints in rodent prenatal hypoxia models. The through-line there is neuronal survival and signal integrity, not endocrine output.

Here is the distinction most epitalon vs pinealon comparisons miss completely. The name Pinealon implies pineal origin, but the bulk of its published work is neuronal. Epitalon, with the less obvious name, is the one descended from a pineal preparation. Researchers who reason from the names alone get the relationship backwards, then build a study around an endpoint the chosen compound has never been tested against.

Research suggests both peptides are small enough to reach the cell nucleus, and the proposed mechanism from the Khavinson group involves sequence-specific interaction with DNA and histone proteins. That mechanism remains a hypothesis under active investigation, not a settled finding, and epitalon vs pinealon debates that assume it as fact are building on soft ground.

Sleep, circadian rhythm, and where DSIP fits

Searches for pinealon vs epitalon for sleep ask one question and deserve two answers, because sleep is not a single endpoint. In epitalon vs pinealon terms, the split is between rhythm and resilience.

Epitalon's sleep-adjacent research is circadian. Melatonin is synthesised in the pineal gland, and the Epitalon literature reports effects on the timing and amplitude of that secretion in aged animals where the rhythm has flattened. If the research question concerns rhythm restoration, that is the Epitalon lane.

Pinealon's sleep-adjacent research is barely about sleep. It is about neuronal function under metabolic stress. Where pinealon and epitalon sleep discussions overlap is in a downstream assumption, that a better-functioning central nervous system sleeps better. That is a hypothesis researchers test, not a result anyone should quote.

DSIP is a third thing. Delta sleep-inducing peptide is a nonapeptide, nine residues, first described in the 1970s from the cerebral venous blood of rabbits during induced delta-wave sleep. In a pinealon vs epitalon vs dsip framing, DSIP is the only one of the three whose original isolation was defined by a sleep phenomenon itself. Labs structuring sleep-architecture work often begin there, which is why DSIP sits alongside the broader sleep support peptide range rather than in the cognition category.

Epitalon vs Pinealon: side-by-side research comparison

The table below sets the three most commonly conflated compounds against the criteria that actually change a study design. Note the regulatory row, which applies identically to all three.

Criterion	Epitalon (AEDG)	Pinealon (EDR)	DSIP	Bottom line for researchers
Sequence and length	Ala-Glu-Asp-Gly, four residues	Glu-Asp-Arg, three residues	Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, nine residues	Three chemically unrelated molecules; no shared motif justifies substitution
Molecular weight	Roughly 390 Da	Roughly 418 Da	Roughly 849 Da	Mass difference is large enough that identity is trivially confirmable on a certificate of analysis
Origin of the molecule	Synthetic analog of Epithalamin, a pineal tissue preparation	Synthetic short peptide from the same bioregulator research programme	Isolated from cerebral venous blood during induced delta sleep	Only Epitalon has a genuine pineal derivation story, despite the naming
Dominant research endpoint	Melatonin rhythm, antioxidant enzymes, telomerase activity in cell culture	Neuronal survival under hypoxia and oxidative stress, apoptosis markers	Sleep architecture, delta-wave activity, stress response	Match the compound to the endpoint being measured, not to the name
Sleep relevance	Indirect, via circadian rhythm research	Indirect at best, via neuronal function	Direct, by definition of its discovery	For sleep-architecture models, DSIP is the literature-supported starting point
Evidence depth	Moderate, concentrated in one research tradition	Thinner, mostly preclinical models	Older literature, mixed replication	None of the three has a large independent replication base in English-language journals
Regulatory status	Research use only, not an approved drug	Research use only, not an approved drug	Research use only, not an approved drug	No human or veterinary use; laboratory research applications only

What If: Common Sourcing and Study-Design Scenarios

What if a supplier lists Pinealon and Epitalon as the same compound?

Treat the listing as a documentation failure and request the batch certificate of analysis before anything else. The certificate should report a sequence, a mass consistent with a three-residue or four-residue peptide, and an HPLC purity figure. If the supplier cannot produce a per-batch document matching the sequence on the label, the identity of the material in the vial is unverified, which makes any comparison between the two peptides meaningless from the outset.

What if a study design calls for pinealon and epitalon together?

Co-exposure designs exist in the short peptide literature, but the honest position is that data on a pinealon and epitalon stack is thin compared with data on either compound alone. Questions along the lines of can you take pinealon and epitalon together are consumption questions, and these are research-use-only materials with no human or veterinary application. A researcher designing co-exposure work should hold single-compound arms as controls, because without them any combined effect cannot be attributed to either peptide.

What if the research question is specifically about sleep quality?

Define the measurable endpoint before selecting a compound, because epitalon vs pinealon is the wrong first question for sleep work. Melatonin rhythm amplitude, sleep-onset latency and delta-wave proportion are three different measurements requiring three different models. Real Peptides supplies these compounds for laboratory research only, not for human or veterinary use, and anyone with a question about an animal's sleep or cognition should talk to their veterinarian rather than extrapolate from peptide research literature.

The unglamorous truth about comparing short peptide bioregulators

Let's be direct about this: the evidence base underneath both compounds is smaller and more concentrated than the internet suggests. A large share of the published work on epitalon vs pinealon originates from a single research tradition, much of it published outside high-impact English-language journals, with limited independent replication. That does not make the findings wrong. It does mean confident claims about which peptide is better for sleep, cognition or longevity are running well ahead of the data. Our team has reviewed this literature repeatedly, and the pattern holds every time: strong mechanistic hypotheses, modest replication. The information here is educational and describes published research only.

Researchers working past the sequence table usually need documentation more than they need another comparison article. Pinealon is stocked as a research-grade tripeptide with batch-level analysis, and the focus and cognition peptide collection groups it with the other compounds studied against neuronal endpoints, while the DSIP research peptide sits with the circadian and sleep materials. Every batch across the Real Peptides catalog is produced through small-batch synthesis with exact amino-acid sequencing and ships with a certificate of analysis.

The epitalon vs pinealon question rarely gets settled by piling on more literature, because these two peptides were never competing for the same endpoint. One descends from pineal tissue chemistry and gets measured against rhythms and replicative capacity. The other descends from neuroprotection work and gets measured against neuronal survival under stress. Treating them as rival versions of a single idea is how a study design ends up with a compound that cannot possibly move the endpoint being recorded. Name the endpoint first. The molecule follows from it.

References

Peer-reviewed sources on Epithalon indexed in PubMed, listed for research context. Real Peptides supplies Epithalon for laboratory research use only.

Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties. International journal of molecular sciences, 2025. PMID 40141333. doi:10.3390/ijms26062691
Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. Biogerontology, 2025. PMID 40908429. doi:10.1007/s10522-025-10315-x
The Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic Retinopathy. Stem cell reviews and reports, 2025. PMID 40493162. doi:10.1007/s12015-025-10911-x
Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro. Aging, 2022. PMID 35413689. doi:10.18632/aging.204007
AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism. Molecules (Basel, Switzerland), 2020. PMID 32019204. doi:10.3390/molecules25030609
Effect of peptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on the morphology of the thymus in hypophysectomized young and old birds. Bulletin of experimental biology and medicine, 2013. PMID 23658898. doi:10.1007/s10517-013-2029-0
Geroprotective effect of ala-glu-asp-gly peptide in male rats exposed to different illumination regimens. Bulletin of experimental biology and medicine, 2008. PMID 19110597. doi:10.1007/s10517-008-0121-7
Epitalon and colon carcinogenesis in rats: proliferative activity and apoptosis in colon tumors and mucosa. International journal of molecular medicine, 2003. PMID 12964022

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

No. Pinealon is the tripeptide Glu-Asp-Arg, roughly 418 Da, and Epitalon is the tetrapeptide Ala-Glu-Asp-Gly, roughly 390 Da. They share a research lineage from the same short peptide bioregulator tradition, but no amino acid position matches between them and their published research endpoints differ substantially.

These are research-use-only compounds, not products for human or veterinary consumption, so consumption questions fall outside what any supplier can address. In laboratory terms, co-exposure designs exist in the short peptide literature, but published data on a pinealon and epitalon stack remains thin compared with single-compound research on either peptide.

Epitalon research concentrates on pineal and cellular aging endpoints, including melatonin secretion rhythm in animal models and telomerase activity in cultured human cells. Pinealon research concentrates on neuroprotection, particularly cortical neuron survival under hypoxic and oxidative stress. Different literatures, different measurements, different experimental models entirely.

Neither is a direct sleep compound. Epitalon has the stronger circadian link through published melatonin rhythm research, while Pinealon's connection to sleep is indirect and rests on neuronal function assumptions. For sleep-architecture endpoints specifically, DSIP has the more direct literature because its original isolation was tied to delta-wave sleep.

DSIP is a nonapeptide of nine residues, roughly twice the molecular weight of either Pinealon or Epitalon, and it was first described in the 1970s from cerebral venous blood collected during induced delta sleep. Pinealon and Epitalon are three and four residue peptides from a separate research programme focused on gene regulation.

Check the certificate of analysis for the reported sequence, mass spectrometry result and HPLC purity profile. Pinealon should show a mass consistent with a three-residue peptide near 418 Da; Epitalon should show roughly 390 Da for four residues. The retention profiles also differ, so identity confirmation does not depend on label copy.

No. Neither compound is an approved drug product. Both are supplied as research-use-only materials for laboratory investigation and are not intended for human or veterinary consumption. Any published findings on these peptides come from preclinical models and cell culture work rather than from completed regulatory approval pathways.

Pricing varies widely by quantity, stated purity, batch size and whether per-batch analytical documentation is included, so a single figure would be misleading. Current Real Peptides catalog pricing and available vial sizes are listed on the shop pages, with certificates of analysis published separately for each batch.

Lyophilised short peptides are typically stored at minus 20 degrees Celsius or lower, protected from light and moisture, with reconstituted material refrigerated at 2 to 8 degrees Celsius. Repeated freeze-thaw cycles and temperature excursions degrade peptide integrity in ways that visual inspection cannot detect.

The naming reflects the research programme it came from rather than its experimental focus. Epitalon is the peptide with genuine pineal derivation, as a synthetic analog of Epithalamin. Most published Pinealon work examines cortical neurons under stress, so reasoning from the names alone reverses the actual relationship between the two peptides.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA